HITLAB’s Post

UPMC Enterprises, the venture capital arm of UPMC, is launching the first Women’s Health @ Top of Mind event today, a pivotal pre-summit program hosted at the Center for Connected Medicine at UPMC that unites health experts with the aim of driving tangible progress in the crucial field of #womenshealth. Summit panels will feature insight from several UPMC physicians and leaders across the system, and discussion will surround the pioneering work happening at Magee-Womens Research Institute—the largest women’s research institute in the U.S.—and UPMC Magee-Womens Hospital, a global leader in women’s health care. Specifically, experts will focus on three key areas where tangible progress can be made: - Research: Conducting more studies to understand biological differences. - Access: Ensuring optimal access to the right care at the right time. - Funding: Investing in innovative products that better serve the female population. Learn more about the pre-summit program and view the full agenda: https://lnkd.in/e3twe2nR

The collaboration between Elligo Health Research® and WHYZE Health, an Ireland-based AI Data-as-a-Service platform, marks a significant step towards enhancing healthcare data management and expanding clinical trial access across the U.K. and Europe. What does this mean? 🔵For Healthcare Providers: Comprehensive support to start or enhance clinical research capabilities. 🔵For Patients: Improved access to clinical trials and better representation in research. 🔵For the Industry: A significant boost in community-based research sites, ensuring timely and quality trial enrollments. Elligo CEO Barry Simms emphasises the importance of this collaboration in attracting more diverse patients for trials worldwide. At the same time, WHYZE Health CEO Frances Abeton, MBA, highlights the transformative power of their AI platform in patient empowerment and research accessibility. Together, we're setting a new gold standard in patient-centric care and inclusivity in clinical trials. 🌍🔬 Learn more about this groundbreaking partnership and how it's reshaping the future of healthcare: https://lnkd.in/eStAjFMP

We're looking forward to The Power of Digital Health Partnerships next week organised by Health Innovation Oxford & Thames Valley. If you're there, come and speak to the SBRI Healthcare team - Raffaella Roncone, Charmaine Mulligan and Danilo S. Villanueva Navarrete PhD -about how we can support you and your innovation. We're looking forward to sessions on innovation in Cardiovascular Disease, Data-Driven Health Horizons, AI's role in transforming NHS services, harnessing technology for mental well-being, aligning economic growth and NHS innovation objectives, productivity and Net Zero, the workforce challenge, early stage evidence generation, digital solutions for chronic, improving productivity and more. #digitalhealth #healthinnovationnetwork #healthcare #medtech #healthtech

🌟 The Power of Partnership At USC MESH Strategic Partnerships, we're not just about making connections — we ignite innovation pathways, transforming groundbreaking concepts to improve human health. Our mission is fueled by the Keck School of Medicine of the University of Southern California's Collaborate to Innovate Platform, which weaves a collaborative #meshwork helping Keck faculty at various stages of their innovation journey connect and collaborate with industry. From insightful personalized meetings to the establishment of business development and industry relationships and services, we pave the path for high-impact collaborations and strategic partnerships. As innovators gear up for launch, we open doors to essential resources, such as startup accelerators, incubators, and venture capital connections.   For Industry: At the forefront of life sciences #innovation, the leap from research to market leadership is a path best traveled together. The MESH Team delivers a personalized service to help you navigate and collaborate with our #bioscience innovation ecosystem. We are committed to understanding your needs and building mutually beneficial partnerships that yield long-term value. 🔗 Visit our website https://keck.usc.edu/mesh/ to learn more! #USC #MESH #StrategicPartnerships #Innovation #LifeSciences #Collaboration #regenerativemedicine #neuroscience #metabolicdiseases #oncology #drugdevelopment #AIinMedicine #CollaboratetoInnovate

Here are some of my key takeaways from the MIT Sloan Healthcare & BioInnovations Conference at the MIT Media Lab. It was a great learning experience, particularly for someone with a background in the life sciences. The conference commenced with an insightful presentation by Dr. Robert Fields from Beth Israel Lahey Health, who shed light on the evolving landscape of U.S. healthcare and highlighted key areas where AI can be integrated. His talk underscored the importance of scaling AI-based healthcare solutions, a critical bottleneck currently hindering the rapid adoption of innovative technologies. The panel discussions were equally engaging, covering a wide range of topics, from the transformative impact of AI in healthcare to strategies aimed at enhancing financial accessibility to care. A moment that particularly resonated with me was the fireside chat with Deborah Di Sanzo of Best Buy Health, offering a compelling vision for the future of healthcare at home. The dialogue underscored the need for increased collaboration between AI experts and clinicians to ensure that technological advancements benefit patient care. Moreover, the discussions around patient data protection highlighted the ethical considerations paramount to the adoption of emerging technologies. A recurring theme from the panelists and keynote speakers was the potential of AI to significantly improve healthcare access and efficiency. Specifically, AI's role in streamlining administrative tasks for healthcare professionals presents an immediate opportunity for impact. The advice that resonated most with me was that solutions need not be complex to be effective; simplicity can often lead to significant breakthroughs. Another standout feature of the conference was the Sloan Healthcare Innovations Pitch Competition, showcasing the winners - MabLab, BridgeHealthAI (Bridge: The Health Equity Innovation Lab), and Third Coast Dynamics - and their pioneering solutions poised to shape the future of healthcare. The concluding keynote by Dr. Lisa Neff from Eli Lilly and Company, focusing on the challenges of obesity, emphasized the complexity of addressing conditions that necessitate a shift in societal perceptions. The need to increase awareness and eradicate stigma through educational campaigns was also underscored in the earlier panel discussion on 'Transitions to Over the Counter (OTC) Products.' For those at the intersection of technology and healthcare, the conference was a powerful reminder of the opportunities and responsibilities in the field. Innovation, collaboration, and ethical consideration, all geared towards improving patient care, stand out as key principles guiding the path forward. #HealthcareInnovation #MITMediaLab #AIHealthcare

The proper use of computational models and AI has the potential to reshape modern biotechnology and biopharma. A recap from the MIT Sloan Healthcare & BioInnovations Conference is linked below.

🌟 Reminder: we are holding a public CICA Lab webinar tomorrow evening! 🌟 Are you a clinician considering our Clinician Incubator Program? This is your chance to get a taste of the impactful content we offer! 📅 Date: Tomorrow, 6th of August ⏰ Time: 7pm - 8:30pm AEST ✍ Register here: https://lu.ma/254fuj50 Healthcare innovation within large organisations can be daunting. You might wonder: - Where to begin? - Who to approach for funding? - How to navigate common roadblocks? Many clinicians face these challenges and often decide not to pursue their innovative ideas. But we need clinicians as innovators driving the solutions to our most pressing healthcare challenges! Join us for a complimentary webinar where you'll learn: - How to secure funding and where to find it. - Strategies to deliver your project quickly and effectively. - Key traits of successful innovators. Don't miss out on this opportunity to learn how to make a difference from within healthcare systems, and gain some insight into what CICA Lab can offer to all burgeoning clinician innovators! 🚀 Register here: https://lu.ma/254fuj50 Richard Macliver Dr Amandeep H. Dr Bi, Mian Dr Louise Schaper Sarah Newby Creative Careers in Medicine Australian Medical Angels LaunchVic Shadowboxer WeGuide DEPT® Digital Health CRC #ClinicianInnovators #Intrapreneurs #HealthcareInnovation

The emphasis on patient-centricity has increased potential synergies between life sciences companies and patient organizations—a dynamic that the Institute analyzed in last year’s report, Supporting patients through research collaboration: Interactions between patient organizations and life sciences companies. On April 25, 2024, the Institute shared some of these insights in a webinar, Patient Organization Research Collaborations. This insight brief captures key highlights from the presentation — including a high-level framework for forging more effective collaborations. Check it out here: https://bit.ly/4e1Vg6X. #PatientCentricity #GlobalHealth #DataScience #HealthEquity

🎉 In partnership with Charité - Universitätsmedizin Berlin and Prof. Dr. sylvia mechsner, we’re reimagining how data flows between patients and doctors. Our aim is to optimize consultations and expedite access to high-quality healthcare. Our efforts to capture the patient experience of women living with endometriosis as also been recognized with the Health-X Innovation Prize. Endometriosis affects 1 in 10 women worldwide, yet it takes on average 10 years to get a diagnosis. In Germany, specialized endometriosis centers are overwhelmed, with extensive waitlists due to limited resources, leaving patients in prolonged limbo for essential care. Thanks to the EU-funded Health-X dataLOFT, our technology will securely integrate patient-reported data into Charité’s systems using Gaia-X infrastructure. This gives endometriosis specialists crucial information before consultations, allowing more time for diagnostics and treatment planning, thereby significantly boosting efficiency. We envision a future where patient experiences drive clinical decisions in real time, transforming the way healthcare is delivered. With backing from industry leaders like the Berlin Institute of Health (BIH), OFFIS - Institute for Information Technology, Siemens Healthineers, and the Fraunhofer Institute for Systems and Innovation Research ISI, this vision is becoming a reality as part of the Health-X dataLOFT initiative. To our partners and the Health-X Innovation Forum: Thank you for recognizing the potential of this project. And a big thank you to the mama team led by Dr. Jonas Witt and Katrina Holmes! This is just the beginning... 🚀 Do you suffer from Endometriosis? Feel free to sign up to the platform: https://lnkd.in/eBNnd-TY #REW #RWD #PatientCentricity

#CEODesk 🖊️ Pioneering Inclusive Clinical Trials: Atropos Health Partners with Seqster In an industry where innovation is the cornerstone, a recent collaboration between Atropos Health and SEQSTER is redefining the standards for clinical trials. This powerful alliance is set to break down the barriers in health equity and drive forward the inclusion of diverse patient populations - a move that resonates with the very ethos of precision medicine. 🧪 Charting New Ground in Clinical Research: Atropos Health and Seqster's remarkable initiative reduces the timeline for patient registry setup from years to a staggering 48 hours. By employing real-time data updates and capturing patient-reported outcomes, they're shifting the paradigm towards truly inclusive clinical datasets that can accelerate medical breakthroughs. Broader Impact on the Healthcare Ecosystem: These efforts at enhancing data accessibility and patient registries put Atropos Health and Seqster at the heart of a seismic transformation. By inviting a diverse range of participants, they're ensuring that research and trials reflect actual patient demographics – a critical move in eliminating health disparities. Strategic Perspective in Market Implications: This pursuit of inclusivity in medical research is more than a noble venture; it's a significant market catalyst. It opens up a spectrum of investment opportunities in health tech start-ups focused on diversity and technological innovation. Investment Recommends: 🏥 Backing Tech-Driven Growth: Companies pioneering in data integration and analytics, like Atropos Health and Seqster, are ripe for investment. 🏥 Focusing on Inclusivity: Industry-wide, there's a push for diverse and equitable research practices, marking a strategic entry point for investments. 🏥 Embracing Cost-Efficiency: The alliance sets a new standard for cost-effective clinical trials, unveiling a promising avenue for long-term investments. As leaders in healthcare, how can we further the call for inclusivity to create a lasting impact on both global health outcomes and market dynamics? Join the discussion with #MarketUnwinded as we delve deeper into the far-reaching implications of transformative healthcare strategies. Read More: https://lnkd.in/gyM2tBXP #HealthTech #ClinicalTrialsInnovation #PrecisionMedicine #InvestmentOpportunity #DataIntegration #Leadership #StrategicInsights